drugset / Trial / NCT00847249

AZD9164 Single Ascending Dose Study in Healthy Male Subjects

NCT00847249

Phase 1 Completed 65 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

The aims of the study are to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD9164 following single ascending dose administrations to healthy male subjects.

Timeline

Start
2009-02
Primary completion
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD9164 Small molecule 4 ug Inhaled

Indications

No indication recorded.